Chilton Investment Co. LLC cut its stake in Ingevity Corp (NYSE:NGVT) by 2.1% in the fourth quarter, Holdings Channel reports. The fund owned 1,031,729 shares of the company’s stock after selling 22,253 shares during the period. Ingevity accounts for about 2.8% of Chilton Investment Co. LLC’s portfolio, making the stock its 11th largest holding. Chilton Investment Co. LLC’s holdings in Ingevity were worth $72,706,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Ingevity during the 2nd quarter worth about $333,000. OxFORD Asset Management LLP increased its position in shares of Ingevity by 20.0% during the 3rd quarter. OxFORD Asset Management LLP now owns 165,512 shares of the company’s stock worth $10,430,000 after purchasing an additional 27,624 shares during the last quarter. Smith Asset Management Group LP acquired a new stake in shares of Ingevity during the 3rd quarter worth about $1,138,000. WINTON GROUP Ltd increased its position in shares of Ingevity by 151.5% during the 3rd quarter. WINTON GROUP Ltd now owns 65,528 shares of the company’s stock worth $4,094,000 after purchasing an additional 39,473 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of Ingevity by 4.7% during the 3rd quarter. Ameriprise Financial Inc. now owns 300,514 shares of the company’s stock worth $18,774,000 after purchasing an additional 13,448 shares during the last quarter. 91.37% of the stock is owned by institutional investors and hedge funds.

A number of analysts recently issued reports on NGVT shares. Jefferies Group raised their price objective on Ingevity from $71.00 to $84.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Loop Capital cut their price objective on Ingevity from $83.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, December 26th. BidaskClub raised Ingevity from a “hold” rating to a “buy” rating in a research report on Saturday, November 4th. Zacks Investment Research downgraded Ingevity from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Finally, Rowe reissued an “outperform” rating and set a $90.00 price objective (up from $80.00) on shares of Ingevity in a research report on Thursday, November 30th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $78.17.

Ingevity Corp (NYSE:NGVT) opened at $69.14 on Friday. The firm has a market capitalization of $3,004.10, a PE ratio of 31.60, a price-to-earnings-growth ratio of 2.05 and a beta of 1.20. The company has a debt-to-equity ratio of 1.92, a current ratio of 2.36 and a quick ratio of 1.34. Ingevity Corp has a 52-week low of $52.79 and a 52-week high of $80.18.

COPYRIGHT VIOLATION NOTICE: “Chilton Investment Co. LLC Sells 22,253 Shares of Ingevity Corp (NGVT)” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.dailypolitical.com/2018/02/09/chilton-investment-co-llc-sells-22253-shares-of-ingevity-corp-ngvt.html.

About Ingevity

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NYSE:NGVT).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.